Empower your patients with FreeStyle Libre systems.

Help your patients make more informed choices*1 and achieve better clinical outcomes*2–4.

This is progress.

FreeStyle Libre sensor
FreeStyle Libre sensor
FreeStyle Libre sensor

The #1 CGM prescribed in the US†:

Proven to significantly lower A1C*5.

 

CGM = continuous glucose monitor(ing)

Easy for you and your patients to use*4,6.

More people pay $0 for FreeStyle Libre systems than other CGMs‡7.

Request your sensor samples§ today! 

  • step 1 of 3:Verify <span style="display: block;"> provider name</span>,current
  • step 2 of 3:Enter <span style="display: block;">order details</span>,Pending
  • step 3 of 3:Terms and <span style="display: block;"> Conditions</span>,Pending
 

Please verify your name matches the details below:

*Required

Please provide your first name.
Please provide your last name.
 

*Required

Please enter a NPI code. Please enter a valid NPI code. Please enter a valid NPI code.
Please provide a valid email address. Please provide a valid email address.

*Samples can only be delivered to a valid clinic address:

Please select your clinic address.

 
Please select your clinic or enter a new address to receive your samples.
 
Please enter your address. Max 30 character allowed
Max 30 character allowed
Please enter a valid city. Please enter a valid city.
 
Select
  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • District of Columbia
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
Please enter a valid state.
Please enter a valid ZIP code. Please enter a valid ZIP code.
Please enter your phone number. The phone number entered is invalid
Required Field Max 80 character allowed
 

To opt out of receiving mobile telephone calls and/or emails from Abbott, please call 1-844-330-5535. More information can be found in Abbott's Privacy Policy at www.abbott.com. Please note that even if you opt out of receiving telephone calls and/or emails, Abbott may still communicate with you by telephone and email as necessary to provide you with services and information related to your participation in programs in which you have enrolled.

 

Terms and Conditions

Terms & Conditions

Practitioner acknowledges that, at their request, Abbott Diabetes Care (ADC), located at 1360 South Loop Road, Alameda, CA 94502, is providing FreeStyle Libre Systems product(s) at no charge to Practitioner solely for distribution to patients in accordance with the indications for use.

Practitioner represents and warrants that they are licensed by applicable state law(s) to use or order the use of prescription medical devices in the course of their professional practice. To the extent that the Practitioner’s prescribing authority is predicated on meeting additional state requirements, including, but not limited to, certification from the relevant professional board authorizing prescriptive authority or a collaboration/supervision agreement with a physician that addresses prescriptive authority, they represents and warrants that they comply with any additional requirements.

Practitioner certifies that they will not resell or trade the no charge product(s) and will not seek reimbursement from any patient or third-party payor, including federal health care programs. If the services provided by the Practitioner are covered under global payment systems (such as DRGs), then the no charge product(s) must be treated appropriately under the billing procedures applicable to the payment system.

Practitioner acknowledges that the FreeStyle Libre systems no charge product(s) are for trial use only. Practitioner certifies that they will require each patient to discard/dispose or return any FreeStyle Libre systems no charge product(s) at the conclusion of the patient’s wear experience of FreeStyle Libre systems no charge product.

Practitioner certifies that they are aware that FreeStyle Libre systems no charge product(s) are not approved for inpatient use or for patients in acute care who are critically ill and is provided by ADC for intended use in accordance with product labeling

 

You have already requested samples.

Our records show you have already requested samples. At this time, each provider is eligible for one order only. Please check your email for your previous order information.

Thank you for requesting your FreeStyle Libre 3 Plus sensor samples!

Here’s what to expect next:

Step 1: Check your inbox for a confirmation email from Abbott.

Step 2: Upon shipment of your samples, you will receive an email containing the tracking information for your order.

Step 3: Once your samples are delivered, a follow-up DocusignTM email will be sent to you to confirm the receipt of your samples.

For any order questions, please contact SampleSupport@abbott.com. You can learn more about prescribing FreeStyle Libre systems below.

Have Questions?

Explore the FAQs below and contact us at SampleSupport@abbott.com if you have further questions.

What is the FreeStyle Libre Sampling Program§?

This is an invitation-only program through which Abbott's Diabetes Care team is providing healthcare providers samples§ of FreeStyle Libre systems sensors, to enable more patients with diabetes to experience the benefits of the FreeStyle Libre systems.

Who is eligible for the FreeStyle Libre Sampling Program§?

Healthcare providers who participate in Abbott’s email education program may be eligible to request samples§ of FreeStyle Libre systems sensors.

Government employees are not eligible to receive free samples from Abbott.

The sensor samples§ are intended for patients with diabetes who can benefit from a continuous glucose monitor.

Additional order questions?

If you have any questions in regards to your order, please contact SampleSupport@abbott.com.

Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.

* Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.

† Based on retail and durable medical equipment (DME) sales data for patient’s last-filled prescription, by manufacturer.

‡ Based on prescription claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus competitors’ CGM systems. Does not include fee-for-service Medicare, fee-for-service Medicaid, and uninsured patients. The actual amount a patient pays may vary. The FreeStyle Libre personal CGM systems require a prescription.

§ The sample is provided to you with no requirement or obligation.

References: 1. Fokkert, Marion, et al. "Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4)." BMJ Open Diabetes Research and Care 7, no. 1 (2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 2. Bolinder, Jan, et al. "Novel Glucose-Sensing Technology and Hypoglycaemia in Type 1 Diabetes: a Multicentre, Non-masked, Randomised Controlled Trial." The Lancet 388, no. 10057 (2016): 2254–2263. https://doi.org/10.1016/S0140-6736(16)31535-5. 3. Evans, Mark, Zoë Welsh, and Alexander Seibold. "Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for Up to 24 Months: a Meta-analysis of 75 Real-World Observational Studies." Diabetes Therapy 13, no. 6 (2022): 1175–1185. https://doi.org/10.1007/s13300-022-01253-9. 4. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicentre, Open-Label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 5. Evans, Mark, et al. "The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-analysis of Clinical Trials and Real-world Observational Studies." Diabetes Therapy 11, no. 1 (2020): 83–95. https://doi.org/10.1007/s13300-019-00720-0. 6. Alva, Shridhara, et al. "Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System." Diabetes Therapy 14, no. 4 (2023): 767–776. https://doi.org/10.1007/s13300-023-01385-6. 7. Data on file. Abbott Diabetes Care, Inc.

Important Safety Information

FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.

No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States.

ADC-95732 v2.0

You are about to leave for a 3rd party website

The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.

Do you wish to leave this site?